Chemoinformaics analysis of 4-Hydroxy-4-isopropyl-2-cyclohexene-1-one
Molecular Weight | 154.209 | nRot | 1 |
Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
Exact Molecular Weight | 154.099 | nRing | 1 |
Solubility: LogS | -1.146 | nHRing | 0 |
Solubility: LogP | 0.939 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.9691 |
nHD | 1 | BPOL | 14.9129 |
QED | 0.618 |
Synth | 3.649 |
Natural Product Likeliness | 2.937 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.317 |
MDCK | 0.0000286 |
BBB | 0.998 |
PPB | 0.574353 |
VDSS | 0.834 |
FU | 0.499307 |
CYP1A2-inh | 0.033 |
CYP1A2-sub | 0.492 |
CYP2c19-inh | 0.048 |
CYP2c19-sub | 0.763 |
CYP2c9-inh | 0.027 |
CYP2c9-sub | 0.277 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.121 |
CYP3a4-inh | 0.029 |
CYP3a4-sub | 0.4 |
CL | 9.739 |
T12 | 0.79 |
hERG | 0.023 |
Ames | 0.109 |
ROA | 0.759 |
SkinSen | 0.848 |
Carcinogencity | 0.901 |
EI | 0.939 |
Respiratory | 0.886 |
NR-Aromatase | 0.016 |
Antiviral | No |
Prediction | 0.93884 |